8-K 1 v104150_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
February 12, 2008
 
RESPONSE GENETICS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
 
000-1124608
 
11-3525548
(State or other jurisdiction of
incorporation or organization)
 
(Commission
File Number)
 
(IRS employer
identification no.)
 
1640 Marengo St., 6th Floor
Los Angeles, California 90033
(323) 224-3900
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 

ITEM 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) On February 12, 2008, the compensation committee of the board of directors (the “Compensation Committee”) of Response Genetics, Inc. (the “Company”) awarded bonuses to its named executive officers, based on their performances and their achievement of Company and individual goals for the year ended December 31, 2007, in the following amounts:

Executive Officer
  
Amount of Bonus
  
Kathleen Danenberg, President & Chief Executive Officer
  
$
175,000
  
Thomas Stankovich, Vice President, Chief Financial Officer and Secretary
  
$
80,000
  
James Clark, Vice President & Chief Operating Officer
  
$
80,000
  
Denise McNairn, Vice President & General Counsel
  
$
80,000
  
 
 
 
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
RESPONSE GENETICS, INC.
 
 
 
 
 
 
Dated: February 15, 2008
By:
/s/ Kathleen Danenberg
  
 
 
Kathleen Danenberg
President & Chief Executive Officer